NDC 84067-476 - Stick
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 84067-476
- Package NDCs from labels
- 84067-476-01
- Manufacturer
- Shantou Youjia E-Commerce Co., Ltd.
- Effective date
- 2024-03-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SOUTH MOON Quit Stick | Shantou Youjia E-Commerce Co., Ltd. | 2024-03-15 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TheraPlus Plus | MENTHOL | Zhejiang Jingwei Pharmaceutical Co., Ltd. | d4119f84-eb60-4134-b58e-de13d9601199 | 2023-10-24 | Warnings | L7T10EIP3A |
| NUMOTIZINE | MENTHOL | Hobart Laboratories, Inc. | 9a29ad1b-4ba3-403f-90c9-ee7582fe4535 | 2023-10-20 | Warnings | L7T10EIP3A |
| ZYLOTROL MAXIMUM PAIN | LIDOCAINE 4%, MENTHOL 1% | Asclemed USA, Inc. | 0bdfe510-c2ff-4f23-9e9b-6ec6cb5c91dd | 2023-10-20 | Warnings | L7T10EIP3A |
| Zylotrol | LIDOCAINE HCL 4%, MENTHOL 1% | Asclemed USA, Inc. | e13984ea-73a9-2894-e053-2995a90a8ed6 | 2023-10-16 | Warnings | L7T10EIP3A |
| EXOTEN-C | METHYL SALICYLATE, MENTHOL, CAPSAICIN | Asclemed USA, Inc. | 76ed37e0-64b5-4abe-a03c-3dc7084a3919 | 2023-10-16 | Warnings | L7T10EIP3A |
| Calypxo Pain Relief | METHYL SALICYLATE, MENTHOL | Asclemed USA, Inc | bd9d0bc0-5705-4c73-bcd6-f6cdb68e05b6 | 2023-10-16 | Warnings | L7T10EIP3A |
| Calypxo HP Pain Relief | METHYL SALICYLATE, MENTHOL | Asclemed USA, Inc | 89a8c267-bd92-4d0d-8e50-c52224aff9cd | 2023-10-16 | Warnings | L7T10EIP3A |
| Zylotrol | LIDOCAINE HCL 4%, MENTHOL 1% | Whitestone Products LLC | 0e32e9c0-ff5b-4e88-89b1-f5903cd98209 | 2023-10-16 | Warnings | L7T10EIP3A |
| Cough Drops | MENTHOL | Topco Associates LLC | 06d2c6cf-0adb-91b9-e063-6294a90aff52 | 2023-10-03 | Warnings | L7T10EIP3A |
| WHITE FLOWER STRAIN RELIEF | CAMPHOR, MENTHOL AND METHYL SALICYLATE | HOE HIN PAK FAH YEOW MANUFACTORY LTD | 65282267-de63-453a-a686-f8752c71b9ef | 2023-10-02 | Warnings | L7T10EIP3A |
| WHITE FLOWER ANALGESIC BALM FLORAL SCENTED | CAMPHOR, MENTHOL AND METHYL SALICYLATE | HOE HIN PAK FAH YEOW MANUFACTORY LTD | 4e9cb5aa-b0aa-4a5c-b561-cc38437758d8 | 2023-10-02 | Warnings | L7T10EIP3A |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | AZELAIC ACID, SALICYLIC ACID | ANUBIS COSMETICS SL | ebf3153d-30f5-54e4-e053-2995a90a74b1 | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID | ANUBIS COSMETICS SL | eca95dde-cb57-2ab6-e053-2995a90af84f | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | SODIUM BICARBONATE, ALOE BARBADENSIS LEAF JUICE, IMIDAZOLIDINYL UREA | ANUBIS COSMETICS SL | ebf4b3ab-34e1-185a-e053-2a95a90ace3a | 2023-09-05 | Warnings | 059QF0KO0R |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | DMAE | ANUBIS COSMETICS SL | f22b212d-d21d-5984-e053-2995a90a683e | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.